Viemed Healthcare, Inc.
VMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14% | 6.6% | -2.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.5% | 57.7% | 56.3% | 59.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.3% | 19% | 17.7% | 21.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.9% | 5% | 4.4% | 7.1% |
| EPS Diluted | 0.09 | 0.077 | 0.06 | 0.1 |
| % Growth | 17.2% | 28% | -40% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |